Episode 254

A Medical Device Pioneer Discusses Remote Possibilities – Dr. David Albert, Founder of AliveCor

02-17-2022

A new generation of medical technology has produced endless new rivers of biometric data, and attuned regular people to their own health in new and complicated ways. On today’s episode of Raise the Line, we turn to a pioneer in connected medical devices, Dr. David Albert, to understand more about these influential trends. He founded AliveCor, whose smartphone-enabled heart monitors anticipated the remote monitoring technology that helped the medical system run during the pandemic. Dr. Albert believes the technology -- and the population-scale data it produces -- opens up new possibilities for preventative medicine and, as he tells host Shiv Gaglani, allows patients to be increasingly fluent in the dynamics of their personal health and empowered to take control of their medical future. Check out this lively discussion to hear about a “mobile-first” medical future, Dr. Albert’s early forays into inventing medical technology, and how college wrestling prepared him for healthy aging.

Transcript

Shiv Gaglani: Hi, I'm Shiv Gaglani. The boom in connected medical devices shows no signs of slowing down, as more providers and consumers embrace digital tools that provide biometric data for personal or clinical use. Today on Raise the Line, we're going to get a unique perspective on how the space has developed and where it is headed with Dr. David Albert, one of its pioneers, who I had the pleasure of meeting nearly a decade ago in D.C. at one of the first mobile health—or mHealth—summits. We've been friends since. Many of the people we've had on the podcast, including Dr. Iman Abuzeid, who is at Incredible Health, started their digital health careers at AliveCor, which is the company Dr. David started.

Dr. David is a physician, inventor, and serial entrepreneur who has developed life-saving technologies and products over the last 30 years, some of which have led to successful startup companies. He's perhaps best known for bringing AliveCor's smartphone heart monitoring devices to the market a decade ago, which have become an essential tool for clinicians and patients all over the world... and very prescient given the remote patient monitoring we need for COVID.

The company has continued to expand its products and global reach in recent years, and I'm really looking forward to learning more about what they've been up to in the last few years today. So, Dr. David, good to see you again.

Dr. David Albert: Shiv, it is a pleasure, my friend.

Shiv Gaglani: I know a lot about you and your background having spoken to you for nearly a decade. But for our audience, many of whom are medical students like your son was a couple of years ago, what got you interested in medicine? And what made you become an inventor and start-up entrepreneur?

Dr. David Albert: It's not a linear story, unfortunately. I always wanted to be a doctor, Shiv. I thought that in my youth. I didn't come from a medical family, don't have anyone else in medicine in my family, but I was fascinated with Dr. Kildare and Ben Casey, the neurosurgeon on television, and my pediatrician, a guy named Fred Burke in Washington, D.C. Those things inspired me to always want to be a doctor. Throughout grade school, middle school, high school, I was a science-focused person.

I went off to our shared alma mater, Harvard College, and was a pre-med. Then I went to Duke Medical School, and I was always thinking I was going to go back. My dad had heart problems and thought I would be an academic cardiologist. I was always interested in research. At Duke, I was able to get into research, and my dad had a heart attack back in Oklahoma where we lived. I went back there. After his heart attack, they told him—this is about 1981—they said “you need to exercise, walk until your heart rate gets to 120." And I said “this 73-year-old man, there’s no way he's going to be able to measure his heart rate." There were no Apple Watches. There were no Polar Chest Straps. There was nothing in 1981.

I spent $200 with a biomedical engineering grad student at Duke to try to get him to build me a heart monitor that my dad could use, and he failed. My $200 went down the drain. That so upset me that I went to my dad, and I went to the dean of the school of engineering, the dean of school of medicine, and I said, "I want to become an engineer so that people can't bamboozle me anymore." I took a leave of absence with only eight months left of medical school and spent two and a half years in engineering school at Duke -- undergrad courses, and then graduate courses -- then went back and finished medical school and went back to Oklahoma.

But in the meantime, I'd already made two inventions: An ultrasound machine and a wrist-based heart monitor, which I ultimately licensed. I went back to do my training at the University of Oklahoma, and I came up with another invention. By the way, I got married and I had a baby. One of your shared classmates, Katherine Albert, my oldest child. What happened was nobody wanted to license that invention.

I went to the chief of cardiology, a guy named Dr. Ralph Azera. He's passed away now. I said, "I want to go start a company." That started my odyssey back in the late 1980s of being an entrepreneur. Never planned to be an inventor. Never planned to be an entrepreneur. Ultimately, I started a company and sold it. Then I started a company called Data Critical and we went public in 1999, and then we sold to GE Healthcare in 2001.

A little over a decade ago, I started AliveCor, and today I have 75 patents and our products are literally used by millions of people. It's not been a linear journey, nor was it a planned journey, but like every good entrepreneur, it's a journey of opportunity and seizing the day. Carpe Diem.

Shiv Gaglani: I remember seeing one of the first AliveCor cases that you brought to the mHealth summit a decade ago and being so impressed. It was like that Arthur C. Clarke quote: “Any sufficiently advanced technology is indistinguishable from magic." Kind of the same feeling a lot of people got when they first even used an iPhone in 2007- 2008, when they saw the touchscreen.

You've come a long way in that past decade. We got to know each other really well when I coordinated that smartphone physical for TedMed and AliveCor ECG. The iPhone case was probably the highlight of that experience. Can you tell us a bit about the last few years, because right now remote patient monitoring is all the rage, digital health is all the rage, with several IPOs and big funding announcements in the last 2-3 years. What have the last couple of years been like with COVID for AliveCor, and for you?

Dr. David Albert: Well, it's an amazing thing, without naming names, we've been going along building our presence. Today, we have 175 peer-reviewed papers. Every major medical center uses AliveCor cardio products, but in 2018, maybe the world's biggest company decided to add personal ECG functionality to one of their products. And of course, a lot of people said, "Oh, well, that'll kill AliveCor." I can tell you, we've only grown 650% since then because this notion of personal ECG was validated.

Our chairman of the board and lead investor—a very well-known guy named Vinod Khosla-- said, "It's the best thing ever happened to you. You were out there in the wilderness by yourself, a little voice, and then, this huge voice comes out and says, ‘this is important, people should have this.’ All of a sudden, you're the experts. They're not. You're the guys who have all the publications, all the IP, all the science." And so today, we have a 6-lead ECG device, our KardiaMobile 6L that can give you half of the 12 lead ECG.

Two days ago, we introduced our Kardiamobile card, which is literally a credit size device. Fits in your wallet. We have lots of other opportunities from inside our app. You can have a board-certified cardiologist review your ECG and send it back. We have relationships with basically everybody. Full disclosure, Mayo Clinic is an investor, big research partner. We support research and validation efforts all over the world. We are in 47 countries. We have over 50 patents for AliveCor and lots of new products both in the last few years -- like the KardiaMobile 6L and the KardiaMobile Card -- as well as new service offerings.

We have a partnership with Omron. They're also an investor, and they integrated our ECG technology into something called Omron Complete. It's a blood pressure machine with ECG. We sell their blood pressure device as part of a remote monitoring service. 

What happened, Shiv, when COVID hit, is it was a catalyst for remote patient monitoring. Our business took a step up. While many people were hurting, it just blew our business up. And that has been sustained even though hopefully, we’re going to be seeing the tail of COVID. It will be a significant tail, but it's the tail nonetheless.

It was a huge stimulus to our business, and it's changed medicine. The issues are, will that change be permanent? Will the laws be changed on reimbursement of telecare? Will the incentives be equalized? I don't have a crystal ball, but I believe that patients and payers can find alignment and that remote patient monitoring and telehealth are here to stay.

Shiv Gaglani: A hundred percent. That's definitely a theme that's come up multiple times in our Raise the Line podcast—both the spike in telehealth utilization and remote patient monitoring. People are very familiar with the technology. I remember in the wilderness of digital health back in 2012 to 2017 or so, I think we were very much in the zone of the disillusionment trough in the Gartner Hype Cycle, and then obviously with COVID, it's become essential.

We've had people on the podcast talk about not just that trend, but the consumerization of healthcare. Ann Wojcicki at 23andMe was on, and a mutual contact of ours, Dr. Eric Topol was on. He wrote that book, The Patient Will See You Now. We talked about the consumerization of healthcare. You're a physician who's developed these products that have truly consumerized, or brought very affordable ECG monitoring to the masses.

One of the biggest things physicians, who are laggards or late adopters, have complained about with this type of technology: How are they going to keep track of the data? Is it leading to the cyberchondria? Where do we stand with that and those consumerization pieces? How do you respond to that? Because I remember a decade ago, many physicians did not want this type of technology to come out.

Dr. David Albert: You're absolutely right. No doubt about it. We had a lot of resistance in the beginning. You're right, 2012 to 2017 was the trough of disillusionment in the Gartner Hype Cycle. However, we've gotten much smarter. The growth of AI -- we're big proponents of AI -- the growth of cloud computing, the notion of ubiquitous data wherever you are…we've gotten better at managing that data and managing for physicians. We have a portal called KardiaPro that allows physicians and the people that work for them to efficiently review and process data. We have interfaces into Epic, and as of a day or two ago, I don't even know if it's public, interface into Cerner at the Oklahoma Heart Hospital in Oklahoma City. Those are the two big EMR platforms.

I would tell you that there is no doubt that the consumer is going to be a partner in their own care. They have to be, Shiv. If we want people to be compliant and we're going to ask them to pay more money…I mean co-pays and deductibles are going only in one direction: up. That's why companies like Livongo went to self-insured employers and said, "We can help you reduce your costs." Because all they've seen for the last twenty years is a step-function increase every year in their healthcare costs. We've got to engage consumers, and while not every consumer's a patient, every patient's a consumer.

We've got to engage them in their care. We have to make them partners. We have to get doctors to accept ,that it's not the old paternalistic system. Certainly, when I trained it was still, "Do what I say or else you're not smart." That doesn't work anymore. That Topol book, The Patient Will See You Now, I think those are all very real trends that are accelerating. We in medicine have to adapt to those trends, and it's going to be tough.

There was a small business book written in the late 1990s: Who Moved My Cheese? It was all about could people adapt to change? And there are those people who were with it readily and those people for whom change was difficult, and I think we're finding that out now. It's not going to stop. The change will continue. You have fee-for-service, volume-based finances going to quality-based finances and shared risk -- things that the health care systems are not used to. But those are inevitable changes, and I think we in the ether between traditional healthcare technology and traditional consumer electronic technology will help bridge that gap and hopefully make it better for both the patients and the providers.

Shiv Gaglani: Absolutely. I couldn't agree more. I think a big missing piece that a lot of other remote patient monitoring or digital health companies that are not nearly as far along as what've you and AliveCor have done, is the AI component. I know you have several FDA-approved algorithms for taking this massive data set you could be getting, which to a physician receiving a random strip at 2 a.m. could be very difficult. It could be very life-saving, but also could be kind of a liability to do that. That was definitely a concern that came up during the trough of disillusionment phase. Can you give us a sense of the size and scope of your database of strips, and some of the coolest AI applications that you're most proud of?

Dr. David Albert: We have well over 130 million ECGs in our cloud database. We have anonymous access to that from our terms and conditions. I don't know who you are, but I have all your ECGs, and its serial. We have some people that have been taking their ECGs daily or weekly, literally for years. I have watched their ECGs and their cardiac pathology evolve. That has enabled us to do some very powerful things. Our KardiaMobile 6L, just in 2021, was cleared to monitor QT. That's a really big deal because before the only thing that could monitor QT was a 12-lead ECG. The FDA gave us first Emergency Use Authorization because early in the pandemic, people were taking Plaquenil and Z-packs, both of which happened to be QT-prolonging medications. They enabled us to use our KardiaMobile 6L to measure QT.

Now, we have a full FDA clearance for that and we have an instant QT service that's AI-based that, by the way, is being used to keep lots of patients safe. Because there are lots of drugs -- chemotherapy cancer drugs, anti-malarial, anti-TB, obviously cardiac drugs like Sotalol and antibiotics -- all of which are QT prolongers. We have great and growing opportunities to use AI to keep patients safe. And I think that's one of my mantras. I always think patients first, Shiv. I think we as physicians, hopefully, we always think patients first.

Shiv Gaglani: Absolutely. We call this the Raise Line podcast because it's about: How do we train more healthcare professionals? How do we make sure our health systems aren't failing? We had Vivian Lee on the podcast, who you know, I’m sure. She was at Google before she ran University of Utah and wrote The Long Fix about value-based medicine, which you touched upon, and how remote patient monitoring can help us get towards that state.

The other half of this is not just raising the line. It's the more well-known term of flattening the curve, because it's very unlikely the way training is set up nowadays that we will be able to reverse this shortage we're seeing of nurses and doctors and other health care professionals.

Dr. David Albert: We burned a bunch of them out! The last two years have been extremely difficult for nurses, for physicians. I can't imagine what it's like for an ICU doctor. I just can't even imagine the last two years. There's been a lot of frustration. At first, it was panic and now it's a lot of frustration when you see what were terrible deaths in the beginning, and now they are potentially preventable deaths. And that's very hard on people, psychologically and physically. They haven't had a let-up.

Hopefully we are getting to the tail of this. Hopefully, we can get our population protected with vaccinations. Hopefully, we can at least get back to some kind of new normal. But in that process, you're right. The population of physicians and nurses and the people who support them has been impacted, and will not keep up with the increasing healthcare demands from old geezers like me. I'm Medicare now, okay? I'm 67. I have an Aetna card, but also a Medicare card. That trend is not going to stop, and we haven't peaked yet in terms of the baby boomers.

It's going to be a challenge for our systems, and if you think ours are bad, just imagine the developing world where they're not going to build the same kind of ivory towers we built in the United States. You've seen the ones at Harvard and at Hopkins, Duke, Columbia, Mayo and Cleveland Clinic. They're not going to build those. They're going to be mobile-first in their access to health care. As Vinod Khosla says, for much of the world, what will probably be their access point is a $30 Android phone. We've got to enable that, not only for them, but for our people. That's value-based care RPM. These are all parts of a bigger solution.

Shiv Gaglani: That's a really interesting part of what you've done with AliveCor over the past decade. There's another quote I really like which is, "The future is already here. It's just not evenly distributed." One of the big complaints about digital health -- it's not a complaint, it's just reality -- is that some of these technologies that are coming out are so expensive that it's just won't be globally accessible.

But with AliveCor, it seems like you have the cutting-edge applications that are used at places like Mayo and Hopkins and places like that, but then you also have the more accessible, AI-driven, credit card size $99 AliveCor ECG monitor. It seems like you guys have been able to reach up and down the spectrum.

Dr. David Albert: Well, we are $79. KardiaMobile today is $79. It was $69 in December for the holidays, but it's $79 from now on. We introduced this KardiaMobile card -- higher-end form factor, more expensive -- but you can get the same quality ECG, the same analysis, the same ability to send your physician at $79. I can promise you that we are committed to enabling accessibility anywhere in the world. It's hard to do it immediately, but as our business grows, we're able to make things more affordable, more accessible. But $79…I don't think we have any peers, to be honest with you. Let alone the fact that we were validated with more publications, more clinical use, more expert support, we're the most affordable. I'm very proud of that.

Shiv Gaglani: Yeah, that combination of quality and access is rare. I think it's a North Star that you guys have been going after, which is great. Wearing your physician hat, I'm curious, with the unusual environment we find ourselves in with what we call at Osmosis the information epidemic, do you have any advice for practicing clinicians or others about how we can turn the tide and get more people to be more health literate, get them more access to their own healthcare data -- which is a premise of AliveCor -- so that we can turn the tide on not just the COVID epidemic but the diabetes epidemic and the heart failure epidemic? There are several epidemics that are largely preventable if we got people to do the right thing for their health.


Dr. David Albert: Well, you know my son, Michael. He's become the Chief Medical Officer of a startup called Accomplish Health, and he's got licenses in 36 States. He's a board-certified internist, and board-certified in obesity medicine. They're going after obesity, which is at the heart of the diabetes epidemic, the hypertension epidemic, the metabolic syndrome epidemic, and then all the consequences that come from those. Alright. That was a shameless pitch for my son. Okay, I admit it.

Shiv Gaglani: He's great! I'm glad you brought him because I was going to bring him up later.

Dr. David Albert: Because we have to address those things. We have to help people learn how to eat. If you go to school in the United States, nobody teaches you what a mortgage means. Nobody teaches you what your healthcare information is. I guess, sometimes, they used to have it, but we didn't have very much information so there wasn't much to cover.

But today, I mean, these are fundamental pieces of knowledge that kids ought to know in middle school. What's a car loan? What's an interest rate? What's compound interest? What's your blood pressure? What's your glucose? What are calories? How does it impact your weight? How does that impact your blood sugar? How does that impact your vascular health?

And I think you know it can't start with doctors. It's got to start with parents, with teachers. I think that's the focus. Somehow our system has come to not only not appreciate expertise and knowledge, but actually disdain it. A significant number of the people in this country now disdain expertise, disdain scientific knowledge. I think that's something, politics aside, that we have to address.

I grew up when we were in the Space Race and the Cold War. Scientists, engineers and physicians were respected by everyone. I don't think that's the case anymore. That's a challenge. Not just for physicians, not just for nurses, not just for teachers, or parents. It's for everybody. We have got to take some of these things out of the domain of medicine -- like your weight, calories -- and distill it down. Of course, here, we look at it as a commercial opportunity, right? I've got my Keto diet. I got my low-carb diet. I got my Ben and Jerry's diet, whatever.

The reality is there are just some fundamental scientific principles that are not difficult. Calories in, calories out. You lose weight because you go on a caloric deficit. That's it. There is no other way. It's not ultrasound. It's not colonic cleanses. It's calories in, calories out. But it's very hard for a lot of people for some very, very well understood biological reasons.

Obesity is a disease, as my son keeps telling me, and we now have better ways to treat it. They're not inexpensive. It's not just, "Oh, you eat too much. You're a weak person and therefore you're going to be a Type 2 diabetic and therefore you're going to get half your foot cut off and therefore you're going to get heart disease, you're going to have a heart attack and you're gonna die." No, we have to start early and teach kids about nutrition, about health, about science, about finance, and get them back respecting knowledge.

Shiv Gaglani: Again, you're preaching to the choir. Osmosis has hung our shingle up on that premise…that we've got to make things simple, accessible, educational and turn the tide, and get people more engaged. I think companies and products like what you've built with AliveCor and what we've done…

Dr. David Albert: You're the Khan Academy for medicine, so bravo to you, Shiv.

Shiv Gaglani: Thank you. Thank you. Yeah, and literally Khan Academy, because a bunch of our team came from Khan Academy, and we had Sal Khan on the podcast. That's all good. But you've done a great job, too. I obviously love your post about new research papers and AI patents and whatnot that you've gotten out there. But another thing that you've been posting is your own personal commitment to health and fitness.

You're very young, actually. We've had people like Alan Patricof from Primetime Partners on our podcast. He's 87 and he stays fit, biking 50 miles a week. What's your secret? Do you have specific goals in mind? I know you're still doing pull-ups and push-ups.

Dr. David Albert: The good news is, Shiv, the last time I was visiting our alma mater, I went by the wrestling room. I was a four-year varsity wrestler. I was a Division 1 wrestler. I'd been a two-time high school All-American. I learned how to work out and exercise and diet at a young age just because it was the sport I was in, and I've carried that on.

Forty years ago, you didn't lift weights or do resistance training for health. It was cardio, cardio, cardio, cardio. Well, now we know if you lose muscle mass, which is inevitable as our testosterone goes down—whether you’re a man or woman—you become frail and your mortality increases. Resistance exercise and cardio are critical elements along with eating well.

I hate to tell everybody out there, but alcohol is a double-edged sword. If you're going to drink, really please do so in moderation, because we know it can impact a number of issues. It's a lot of maybe tasty, yet needless calories. Lifestyle is important, diet is important, exercise is important. But then there's your mind. Mindfulness, meditation relaxation. These are all critical elements to having a good life.

I'm 67 years old, but I don't embarrass myself in the gym. Let's put it that way. I feel good. I see a lot of my peers, my classmates, and they haven't had that same kind of long-term commitment. Maybe they didn't learn it. Maybe I was forced by my sport to learn about diet, to learn about exercise and learn about weightlifting, learn about conditioning, and I've carried it on.

My son, Michael is doing his first half marathon. In college, I think he drank more than one or two beers a week. And med school is a grind, but he's become a very committed guy and I got him into being a board-certified obesity doctor. He does virtual obesity medication and management in more than 30 states. He's committed to a lifestyle because he understands.

When you prevent in medicine, you're doing the highest form of medicine. We're so good at treating your triple vessel coronary disease or your cancer. We're really good at it. We spend a lot of money, and we get what I would call excellent outcomes in this country. But it'd be a lot better if you didn't have to have that bypass surgery, that stent, that cancer surgery. To optimize your health means taking care of yourself. I try to practice what I preach, Shiv.

Shiv Gaglani: I love that. I know we're coming up on time, Dr. Dave, so I have two questions for you. The first is, we have an audience of over two million current and future health care professionals. Your son is one of them. What is your advice to this next generation of healthcare providers about meeting the challenges of COVID and beyond?

Dr. David Albert: It's not appropriate to just say ‘suck it up.’ That's kind of an old notion. The old notion of medicine was, "You just got to tough it out. You need to stay up fifty hours in a row and still be compos mentis.” And we know that's all just, excuse me, crap. You've got to take care of yourself. You cannot take care of your patients and you cannot take care of your family unless you take care of yourself first.

We've got a big problem of burnout in medicine. We’ve got to be aware of that. We will get past this pandemic. Hopefully, some of the lessons we've learned about taking care of yourself, protecting yourself, protecting your family, educating your patients will carry on beyond this. We’ve learned some things in the pandemic, like the value of remote patient monitoring. If I can predict you're going to decompensate your heart failure, maybe I can tell you to take two more 100 milligram Lasix pills and prevent that hospitalization. I think these are some of the lessons that this incredible pandemic has brought to us. Let's hope we take advantage of them.

Shiv Gaglani: 100%. You would love to meet Dr. Johannes Vieweg, who we had on the podcast, who runs Nova Southeastern University. He's adapting his curriculum to have some of those things in mind that you just shared there. Is there anything else you'd like our audience to know about you or AliveCor, remote patient monitoring, and anything else?

Dr. David Albert: Take care of your heart. You should know what your weight is. You should know what your blood pressure is. I think sometime in the next few years, you'll be able to know what your serum glucose is and know how it responds to beer or an ice cream cone. Again, that will go hand-in-hand with us educating you about those metrics about yourself. I hope that both doctors and patients can work in a partnership.

You can't stop death. You just need to stop it before it's time. Live your life a long time in good health. And I think that's going to take that partnership between health care providers and patients. So, if I have a lesson to leave with, it's that.

Shiv Gaglani: That's a great lesson to end on. With that, Dr. David, it’s so great reconnecting with you. Congrats on all the success and the amazing job you've done with AliveCor, and the work that you're doing to help raise line and flatten the curve.

Dr. David Albert: Thank you, Shiv. It's my pleasure, and it's great to hear from you. Good luck at Elsevier. I gave them a lot of money for a lot of research publications. So wonderful. Thank you.

Shiv Gaglani: Thank you again. With that, I'm Shiv Gaglani. Thank you to our audience for checking out today's show. And remember to do your part to flatten the curve and raise line. We're all in this together. Take care.

 

A Medical Device Pioneer Discusses Remote Possibilities – Dr. David Albert, Founder of AliveCor